Dr Jess Kerr-Gaffney
Research Associate
Research
Psychoactive Trials Group
Psychoactive Trials Group
Lithium versus Quetiapine in Depression (LQD) study
Researchers at King's College London ran the LQD study to find the effectiveness of lithium and quetiapine in the treatment of difficult-to-treat depression.
Project status: Completed
News
Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium
New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...
Research
Psychoactive Trials Group
Psychoactive Trials Group
Lithium versus Quetiapine in Depression (LQD) study
Researchers at King's College London ran the LQD study to find the effectiveness of lithium and quetiapine in the treatment of difficult-to-treat depression.
Project status: Completed
News
Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium
New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...